Navigation Links
Media Statement From Amedisys on Dr. Steven H. Landers' NEJM Commentary on the Future of Home Care
Date:10/22/2010

BATON ROUGE, La., Oct. 22 /PRNewswire/ -- Amedisys, a leading home health care and hospice company (Nasdaq: AMED), commends Dr. Steven H. Landers' commentary on the future of home care in this week's issue of the New England Journal of Medicine. Dr. Landers is a member of the Amedisys Strategic Advisory Board.

Titled, "Why Health Care is Going Home," Dr. Landers' commentary outlines his perspective on the future of home care as an increasingly crucial component of America's health care system. As the director of the Cleveland Clinic's Center for Home Care and Community Rehabilitation, Dr. Landers sees the many benefits of home care on a daily basis. As our country ages and more Americans cope with chronic conditions, Dr. Landers predicts that home care will prove to be the ideal option for care.

"It was enlightening to see Dr. Landers' commentary on the future of home care," said Michael Fleming, MD, Chief Medical Officer for Amedisys. "As our country goes through a health care sea change, it is becoming clear that home care is often the best option for patients, insurers and health care systems. Patients have a desire to stay in their homes and, as such, they are demanding home care. There is also a clear financial advantage to home care, as it is often less costly than institutional care."

Amedisys echoes Dr. Landers' call to adapt the policies and structure of our current health care system to bring patient care back into the home. As an innovator in the home care system, Amedisys has always been an advocate of increased technologies that allow seamless and state-of-the-art home care for physicians and home care professionals.

"During this critical period of policy development, we encourage our health care leaders and policymakers to respond to the demand for increased home care services," Fleming added.

About Amedisys:

Amedisys, Inc. (NASDAQ: AMED) is the nation's leading health care company focused on bringing home the continuum of care. Each day Amedisys delivers personalized health care services to more than 35,000 individual patients and their families, in the comfort of patients' homes. Amedisys has two divisions, home health care and hospice. The Company's state-of-the-art advanced chronic care management programs and leading-edge technology enables it to deliver quality care based upon the latest evidence-based best practices. Amedisys is a recognized innovator, being the first in the industry to equip its clinicians with point-of-care laptop technology and referring physicians with an internet portal that enables real-time coordination of patient care seamlessly. Amedisys also has the industry's first-ever nationwide Care Transitions program. Amedisys Care Transitions is designed to reduce unnecessary hospital readmissions through patient and caregiver health coaching and care coordination, which starts in the hospital and continues throughout completion of the patient's home health plan of care. For more information about the Company, please visit: www.amedisys.com.


'/>"/>
SOURCE Amedisys
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. King Pharmaceuticals and Palatin Technologies Delay Immediate Plans for Phase 3 Clinical Program With Bremelanotide for Erectile Dysfunction
2. Hospital to Hold MRSA Briefing for Media and Community Leaders
3. Superbug Outbreak Calls for Immediate Increased Attention on Infection Control
4. Data Presented at the American Heart Association Scientific Sessions 2007 Demonstrated Increased HDL with ACTOS(R) (pioglitazone HCl) Slowed the Progression of Carotid Intima-Media Thickness in Patients with Type 2 Diabetes
5. The OrthoGlide(TM) Medial Knee Implant Continues to be Accepted as an Alternative to Total Knee Replacement
6. Clinical Data Presented on OrthoGlide(R) Medial Knee Implant
7. HealthMedias Strongest Single Quarter Results: Growth Driven by Product Enhancements, New Partnerships
8. Media Statement: MHA Keystone Center for Patient Safety & Quality OHRP Ruling
9. Cardium and Tissue Repair Companys Excellarate Candidate for Healing Diabetic Wounds Gains Media Focus in Multiple Regions Across U.S.
10. Pharmacyclics Announces Preclinical Results Supporting Development of Its Novel Btk Inhibitor in Immune Mediated Diseases
11. New Data From Phase 3 Study Suggests Tapentadol Immediate Release Effective for Acute Pain From Common Foot Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/14/2017)... 2017  ivWatch LLC, a medical device company focused ... therapy, is pleased to announce it was the Bronze ... Supplies and Equipment at the 2017 Medical Design Excellence ... industry. The award was presented by Medical Device and ... in New York during MD&M ...
(Date:6/11/2017)... 2017  Eli Lilly and Company (NYSE: LLY ... studies of galcanezumab, an investigational treatment for the prevention ... several key secondary endpoints for galcanezumab compared to placebo ... (EVOLVE-1, EVOLVE-2 and REGAIN) will be presented today at ... Boston . "The ...
(Date:6/8/2017)... ANGELES , June 8, 2017   Responding to ... drug oversight and the death of singer Chris Cornell ... on Human Rights International offers a free online ... better educate consumers and families about psychotropic drug risks. ... Ledger , who died from an accidental overdose, has called ...
Breaking Medicine Technology:
(Date:6/23/2017)... (PRWEB) , ... June 23, 2017 , ... ... plastic surgeon practicing in Newburgh, New York, has recently begun offering three new ... to offering the best cutting-edge procedures and reducing downtime, Dr. Rubinstein is excited ...
(Date:6/23/2017)... ... ... Goodcents Deli Fresh Subs today announced the opening of a new restaurant in ... Kan. 66604 (near 21st and Gage). It is owned and operated by long-time Goodcents ... the Topeka and Bonner Springs, Kan. area. , “Goodcents has such a loyal ...
(Date:6/23/2017)... Georgia (PRWEB) , ... June 23, 2017 , ... ... Negative Breast Cancer Conference from Sept. 18 to 20. , The two-day conference ... (TNBC) subtype with the goal of improving patients’ lives and eliminating racial breast ...
(Date:6/23/2017)... ... June 23, 2017 , ... PureLife Dental is pleased to ... supplier for CDA members. As part of the amalgam separator endorsement, all CDA members ... more than $400 off the retail value. This partnership between PureLife and CDA is ...
(Date:6/23/2017)... CA (PRWEB) , ... June 23, 2017 , ... Ulster ... 26th June, 2017 from 9 am to 3 pm to present to graduate students ... program is an original curriculum project led by The Health Improvement Service of ...
Breaking Medicine News(10 mins):